Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases

ConclusionsThese results indicate that VLPs modulate immune responses in ways which underline their exceptional promise as a  platform for the immunotherapy of allergic disorders. However, clinical evaluations remain limited, and further large-scale and longer-term studies will be necessary to substantiate the efficacy and safety of these novel therapies.
Source: Allergo Journal International - Category: Allergy & Immunology Source Type: research